What is the current price and trading status of 4564.T stock?

4564.T stock is trading at **JPY 21.00** on the JPX intraday session with volume **24,145,600.00** shares and an intraday range **JPY 20.00–21.00**; liquidity is high vs short-term averages.

What are the main valuation metrics for 4564.T stock?

Key metrics: market cap **JPY 7,111,807,773.00**, EPS **-2.83**, PE **-7.42**, price-to-sales **7.43**, and price-to-book **4.06**, reflecting negative earnings and biotech development risk.

How does Meyka AI view 4564.T stock and its forecast?

Meyka AI rates 4564.T with a score of **70.43/100**, grade **B+** (BUY). Meyka AI's forecast model projects yearly **JPY 16.73**, implying **-20.33%** vs current price; forecasts are projections, not guarantees.

What catalysts should traders watch for 4564.T stock?

Watch the earnings and clinical updates scheduled for 30 January 2026, Phase III progress for S-588410, and any licensing announcements; these events drive short-term moves and liquidity.

JP Stocks

4564.T stock: OncoTherapy Science JPY 21.00 on JPX most active, watch 30 Jan

ByDanny Kontos January 7, 2026

The most active JPX ticker today is 4564.T stock as OncoTherapy Science, Inc. trades at JPY 21.00 with intraday range JPY 20.00–21.00 and volume at 24,145,600.00 shares. Market attention is concentrated ahead of an earnings announcement scheduled for 30 January 2026 and heavy intraday turnover versus the 50-day average of 21.78 JPY. We summarise why liquidity, valuation, and upcoming clinical milestones are driving trades in Japan.